Newsmakers

San Diego Newsmakers profiles the people who helped make this region and The Daily Transcript what it is today - a Who's Who of those who have put San Diego County on the map as a thriving region.

Paul Grayson

Chief Executive Officer

Fate Therapeutics Inc.

3535 General Atomics Ct. Ste., 200
San DiegoCA92121
Founded in 2007, Fate Therapeutics focuses on modulating adult, rather than embryonic, stem cells and on induced pluripotent stem cells (iPSC). The company derives its name from the fact that it essentially modulates the stem cell's fate.
In November it closed a $30 million Series B round of financing, bringing the total funding to $50 million. Seattle-based OVP Venture Partners led this round; and the trio that led Fate's Series A -- Arch Venture Partners, Venrock and Polaris Venture Partners also participated.
Fate's principal stem cell modulator is now in clinical trials.
CEO Paul Grayson ensured that the company would be based in San Diego when he joined Fate three years ago. At that time, the three venture groups had already committed to investing in Series A, and the six founding scientists from Boston, San Francisco, Seattle and San Diego had been assembled.

The Daily Transcript's Profiles

Fate Therapeutics modulates stem cells for therapeutic use

Founded in 2007, Fate Therapeutics focuses on modulating adult, rather than embryonic, stem cells and on induced pluripotent stem cells (iPSC). The company derives its name from the fact that it essentially modulates the stem cell's fate.

Search Contacts

Sponsors

Media

Interview with Jody Watkins

Jody Watkins, president and CEO of Watkins Landmark Construction, talks about business fluctuations in the construction industry and outlines his goals for growing his firm.